Brief: Deciphera Pharmaceuticals Q2 Basic EPS USD -0.57
09/08/2023 12:00
Aug 09 (Reuters) - Deciphera Pharmaceuticals Q2 product revenues USD 37.32 million. * Q2 operating income USD -52.775 million * Q2 net income USD -48.562 million * Q2 operating expenses USD 91.079 million
Recent news on Deciphera Pharmaceuticals
See all newsBrief: Deciphera Pharmaceuticals Announces Oral Presentation Of Results From Phase 3 Study of Vimseltinib In Patients With Tenosynovial Giant Cell Tumor
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Japan's Ono Pharma says $2.4 bln Deciphera purchase 'first step' for global expansion
Deals of the day-Mergers and acquisitions